Cargando…

The perceived barriers to insulin therapy among type 2 diabetic patients

BACKGROUND: Problems may arise with insulin treatment, due to patients' perspective towards it leading to refusal. OBJECTIVES: To evaluate diabetic patients' refusal towards insulin therapy, and to assess patients' perception and perceived barriers towards insulin. METHODS: A cross-se...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussein, Amin, Mostafa, Arafa, Areej, Alnomi, Mona, Al-muteb, Shimaa, Alduaiji, Najd, Al-Gazlan, Futoon, Alnemari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Makerere Medical School 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531943/
https://www.ncbi.nlm.nih.gov/pubmed/31148993
http://dx.doi.org/10.4314/ahs.v19i1.39
_version_ 1783420909547159552
author Hussein, Amin
Mostafa, Arafa
Areej, Alnomi
Mona, Al-muteb
Shimaa, Alduaiji
Najd, Al-Gazlan
Futoon, Alnemari
author_facet Hussein, Amin
Mostafa, Arafa
Areej, Alnomi
Mona, Al-muteb
Shimaa, Alduaiji
Najd, Al-Gazlan
Futoon, Alnemari
author_sort Hussein, Amin
collection PubMed
description BACKGROUND: Problems may arise with insulin treatment, due to patients' perspective towards it leading to refusal. OBJECTIVES: To evaluate diabetic patients' refusal towards insulin therapy, and to assess patients' perception and perceived barriers towards insulin. METHODS: A cross-sectionalstudy, where type 2 diabetics participated in the study during a period, February through March 2017. They were interviewed in person by a questionnaire including three sections; socio-demography, medical history and a health belief model, comprising barriers to use insulin. Five points Likert scale was used to measure patients' perception and barriers towards insulin therapy. RESULTS: One fourth (24.4%) of the diabetic patients refused insulin. Among the controlled group, 34.4% refused insulin, while 21% refused insulin among the uncontrolled group. The study showed different barriers towards insulin therapy, including fear of injection, pain, insulin injection needs help from others, fear of hypoglycaemia and embarrassment. CONCLUSION: Diabetics showed a negative attitude towards insulin therapy due to social and psychological factors. The results necessitate the development of a strategy to address problems related with a reluctance to initiate insulin and put a strategy to implement education and better interaction with diabetic team to the stigma from phobia from insulin use.
format Online
Article
Text
id pubmed-6531943
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Makerere Medical School
record_format MEDLINE/PubMed
spelling pubmed-65319432019-05-30 The perceived barriers to insulin therapy among type 2 diabetic patients Hussein, Amin Mostafa, Arafa Areej, Alnomi Mona, Al-muteb Shimaa, Alduaiji Najd, Al-Gazlan Futoon, Alnemari Afr Health Sci Articles BACKGROUND: Problems may arise with insulin treatment, due to patients' perspective towards it leading to refusal. OBJECTIVES: To evaluate diabetic patients' refusal towards insulin therapy, and to assess patients' perception and perceived barriers towards insulin. METHODS: A cross-sectionalstudy, where type 2 diabetics participated in the study during a period, February through March 2017. They were interviewed in person by a questionnaire including three sections; socio-demography, medical history and a health belief model, comprising barriers to use insulin. Five points Likert scale was used to measure patients' perception and barriers towards insulin therapy. RESULTS: One fourth (24.4%) of the diabetic patients refused insulin. Among the controlled group, 34.4% refused insulin, while 21% refused insulin among the uncontrolled group. The study showed different barriers towards insulin therapy, including fear of injection, pain, insulin injection needs help from others, fear of hypoglycaemia and embarrassment. CONCLUSION: Diabetics showed a negative attitude towards insulin therapy due to social and psychological factors. The results necessitate the development of a strategy to address problems related with a reluctance to initiate insulin and put a strategy to implement education and better interaction with diabetic team to the stigma from phobia from insulin use. Makerere Medical School 2019-03 /pmc/articles/PMC6531943/ /pubmed/31148993 http://dx.doi.org/10.4314/ahs.v19i1.39 Text en © 2019 Hussein et al. Licensee African Health Sciences. This is an Open Access article distributed under the terms of the Creative commons Attribution License (https://creativecommons.org/licenses/BY/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Articles
Hussein, Amin
Mostafa, Arafa
Areej, Alnomi
Mona, Al-muteb
Shimaa, Alduaiji
Najd, Al-Gazlan
Futoon, Alnemari
The perceived barriers to insulin therapy among type 2 diabetic patients
title The perceived barriers to insulin therapy among type 2 diabetic patients
title_full The perceived barriers to insulin therapy among type 2 diabetic patients
title_fullStr The perceived barriers to insulin therapy among type 2 diabetic patients
title_full_unstemmed The perceived barriers to insulin therapy among type 2 diabetic patients
title_short The perceived barriers to insulin therapy among type 2 diabetic patients
title_sort perceived barriers to insulin therapy among type 2 diabetic patients
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531943/
https://www.ncbi.nlm.nih.gov/pubmed/31148993
http://dx.doi.org/10.4314/ahs.v19i1.39
work_keys_str_mv AT husseinamin theperceivedbarrierstoinsulintherapyamongtype2diabeticpatients
AT mostafaarafa theperceivedbarrierstoinsulintherapyamongtype2diabeticpatients
AT areejalnomi theperceivedbarrierstoinsulintherapyamongtype2diabeticpatients
AT monaalmuteb theperceivedbarrierstoinsulintherapyamongtype2diabeticpatients
AT shimaaalduaiji theperceivedbarrierstoinsulintherapyamongtype2diabeticpatients
AT najdalgazlan theperceivedbarrierstoinsulintherapyamongtype2diabeticpatients
AT futoonalnemari theperceivedbarrierstoinsulintherapyamongtype2diabeticpatients
AT husseinamin perceivedbarrierstoinsulintherapyamongtype2diabeticpatients
AT mostafaarafa perceivedbarrierstoinsulintherapyamongtype2diabeticpatients
AT areejalnomi perceivedbarrierstoinsulintherapyamongtype2diabeticpatients
AT monaalmuteb perceivedbarrierstoinsulintherapyamongtype2diabeticpatients
AT shimaaalduaiji perceivedbarrierstoinsulintherapyamongtype2diabeticpatients
AT najdalgazlan perceivedbarrierstoinsulintherapyamongtype2diabeticpatients
AT futoonalnemari perceivedbarrierstoinsulintherapyamongtype2diabeticpatients